The scientists at BSRC “Alexander Fleming” perform cutting-edge research, aiming to understand molecular mechanisms of complex biological processes in health and disease. We are also committed to contribute to innovation in medicine, by developing novel therapeutic and diagnostic methods, focusing on immunity and inflammation, cancer, and neurodegenerative diseases. To keep our focus on top-notch research, we recruit at all levels with excellence as the sole criterion and we support our researchers by providing state-of-the science infrastructures and a pleasant working environment. FLEMING is a non-profit organization operating under the auspices of the Greek General Secretariat for Research & Technology and is supported by the Greek government and by national, European and international grants.


06 March 2018

Two Fleming doctoral students (Panagiotis Chouvardas and Rania Semelidou) have been selected to attend the prestigious 68th Lindau Nobel Laureate Meeting, following a nomination by the Onassis Foundation. This year’s Meeting is dedicated to Physiology and Medicine and will bring together 600 young scientists and a record 43 Nobel Laureates.

15 February 2018

In a collaborative study published in Cell Reports, a Fleming Stavros Niarchos fellow uncovered a novel mechanism that determines the number of cortical interneurons in the brain. The research has important implications for improving the effectiveness of cell-based therapies for epilepsy syndromes. PubMed.

14 February 2018

Fleming researchers uncovered a molecular interplay between survival and death pathways in synovial fibroblasts mediating modelled Rheumatoid Arthritis. Their results suggest that combinatorial targeting of the IKK2/RIPK3 axis in chronic polyarthritis will be advantageous over targeting either of these pathways alone. Nat Commun , PubMed, Research highlight in Nature Reviews Rheumatology.

29 January 2018

In a collaborative study published in Nat Med, a Fleming Marie Curie Fellow revealed that aerosolized delivery of active Thyroid Hormone (TH) resolved pulmonary fibrosis in two mouse models through a mechanism that involved improvement of mitochondrial biogenesis and mitophagy in alveolar type II epithelial cells. PubMed.



Seminar 23/03/2018, 13:00. "Patient-derived Organoids for drug development and screening". Sylvia F. Boj, Scientific Director, Hubrecht Organoid Technology.


Visit BSRC Fleming's scientific Publications web page


Visit BSRC Fleming's funding web page


For internal users


For internal users

B.S.R.C. "Alexander Fleming"
34 Fleming Street, 16672 Vari, Greece
Contact us